Related references
Note: Only part of the references are listed.Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
K. Gemzell-Danielsson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial
Annina Haverinen et al.
CONTRACEPTION (2021)
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism
Suzanne Reed et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2021)
Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study
Suzanne Reed et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2021)
Duration, recency, and type of hormonal contraceptive use and antimullerian hormone levels
Lia A. Bernardi et al.
FERTILITY AND STERILITY (2021)
Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals
Eduardo Hariton et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain
Ludovico Muzii et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Ovarian reserve markers in women using various hormonal contraceptives
Selma Kloeve Landersoe et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2020)
Anti-Mullerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
Loes M. E. Moolhuijsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters
Jonathan Douxfils et al.
CONTRACEPTION (2020)
Current use of combined hormonal contraception is associated with glucose metabolism disorders in perimenopausal women
Maria-Elina Mosorin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Estetrol Combined with Drospirenone
Mitchell D. Creinin et al.
OBSTETRICS AND GYNECOLOGY (2019)
Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM)
Stephanie Both et al.
JOURNAL OF SEXUAL MEDICINE (2019)
A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception
Monica V. Dragoman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17β-Estradiol
Salvatore Caruso et al.
JOURNAL OF WOMENS HEALTH (2017)
Endogenous thrombin potential changes during the first cycle of oral contraceptive use
Carolyn L. Westhoff et al.
CONTRACEPTION (2017)
Impact of estrogen type on cardiovascular safety of combined oral contraceptives
Juergen Dinger et al.
CONTRACEPTION (2016)
A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen
Ingrid J. M. Duijkers et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2015)
Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan
K. Birch Petersen et al.
HUMAN REPRODUCTION (2015)
Is There a Correlation Between Androgens and Sexual Desire in Women?
Sarah Wahlin-Jacobsen et al.
JOURNAL OF SEXUAL MEDICINE (2015)
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
Y. Zimmerman et al.
HUMAN REPRODUCTION UPDATE (2014)
The physiology and clinical utility of anti-Mllerian hormone in women
Didier Dewailly et al.
HUMAN REPRODUCTION UPDATE (2014)
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study
Jan Endrikat et al.
CONTRACEPTION (2013)
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism
Vincenzo De Leo et al.
CONTRACEPTION (2013)
Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment
Frank Z. Stanczyk et al.
CONTRACEPTION (2013)
Antimullerian hormone levels decrease in women using combined contraception independently of administration route
Sanna Kallio et al.
FERTILITY AND STERILITY (2013)
Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study
Costantino Di Carlo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Change to Either a Nonandrogenic or Androgenic Progestin-Containing Oral Contraceptive Preparation is Associated with Improved Sexual Function in Women with Oral Contraceptive-Associated Sexual Dysfunction
Susan R. Davis et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial
M. Raps et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive
Christine Klipping et al.
Drugs in research & development (2013)
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study
T. Piltonen et al.
HUMAN REPRODUCTION (2012)
Ovulation-Inhibiting Effects of Dienogest in a Randomized, Dose-Controlled Pharmacodynamic Trial of Healthy Women
Christine Klipping et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives
M. Raps et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception
Ojvind Lidegaard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception
J. G. Bentzen et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive
Wolfgang Junge et al.
CLINICAL DRUG INVESTIGATION (2011)
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function
Ulla M. Agren et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2011)
Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual Life
Salvatore Caruso et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Metabolic effects of contraceptive steroids
Regine Sitruk-Ware et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2011)
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol
Ingrid J. M. Duijkers et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2010)
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial
Santiago Palacios et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2010)
Mechanisms of Estrogen-Induced Venous Thromboembolism
Svetlana N. Tchaikovski et al.
THROMBOSIS RESEARCH (2010)
Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest
Susan Zeun et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2009)
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies
Jan Endrikat et al.
CONTRACEPTION (2008)
Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry.: Comparison with five immunoassay techniques
Valerie Moal et al.
CLINICA CHIMICA ACTA (2007)
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables
Mandana Rad et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Pharmacology of estrogens and progestogens: influence of different routes of administration
H Kuhl
CLIMACTERIC (2005)
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens
HAAM van Vliet et al.
HUMAN REPRODUCTION (2005)
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation:: a randomized
JM Kemmeren et al.
BLOOD (2004)
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women
G Tans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
I Wiegratz et al.
CONTRACEPTION (2003)
Share Paper
